Cary, NC, United States of America

Richard Wayne Hendren


Average Co-Inventor Count = 11.0

ph-index = 4

Forward Citations = 231(Granted Patents)


Company Filing History:


Years Active: 1999-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Richard Wayne Hendren

Introduction

Richard Wayne Hendren is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of hematology through his innovative work. With a total of 4 patents, Hendren has focused on developing compounds that have the potential to improve treatment methods for hematological disorders.

Latest Patents

Hendren's latest patents include groundbreaking work on labeled compounds that bind to a thrombopoietin receptor. These patents describe peptides and peptide mimetics that not only bind to but also activate the thrombopoietin receptor. Such innovations are particularly useful in treating hematological disorders, especially thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions. Additionally, these peptides and mimetics can be employed in diagnostic methods, enhancing the effectiveness of medical treatments.

Career Highlights

Throughout his career, Hendren has worked with prominent companies such as Glaxo Group Limited and Glaxo Wellcome Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field, further advancing his research and innovations.

Collaborations

Some of Hendren's notable coworkers include William J Dower and Ronald W Barrett. Their collaborative efforts have contributed to the development of innovative solutions in the medical field.

Conclusion

Richard Wayne Hendren's contributions to the field of hematology through his patents and collaborations highlight his dedication to improving medical treatments. His work continues to pave the way for advancements in the treatment of hematological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…